Skip to main content
. 2017 Jun 22;2017(6):CD011947. doi: 10.1002/14651858.CD011947.pub2

Imamura 1989.

Methods RCT (translation); participants randomised (only 1 wound per person)
 Funding: unclear. Setting: hospital inpatients
 Duration of follow‐up 8 weeks (also reported at 1, 2, 4, 6 weeks)
 Unit of analysis: person (1 ulcer/person)
Participants 141 participants with pressure ulcers. PU Stage: I (23% and 21%), II and III (44% and 38%) and IV (34% and 41%) (PU classification: not stated)
 Age: not stated/translated. Duration of ulcer: not stated/translated. Ulcer size: not stated
 Wound characteristics at baseline: unclear infection; slough not reported; necrosis not reported; exudate not reported
 Comment: number with change in infection status reported, but unclear what sort of change
Interventions Group 1: topical ‐ sugar plus povidone iodine: sugar 70 g/100 g and povidone iodine 3 g/100 g; ointment applied directly on the wound or applied on a sheet of gauze and then applied on the wound once or twice a day; n = 72. Grouped intervention category: sugar plus povidone iodine
 Group 2: other topical ‐ lysozyme ointment (5 g/100 g ointment applied directly on the wound or on a sheet of gauze and then on the wound once or twice a day); n = 69.Grouped intervention category: lysosyme ointment
Outcomes Primary outcomes: complete healing not reported; time to complete healing not reported
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Selection bias Unclear risk Sequence generation adequate ‐ random number tables. Allocation concealment adequate ‐ central randomisation with contact details or list held independently. Baseline comparability unclear ‐ baseline difference but unclear of importance. Rating: unclear
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Other evidence for no blinding
Incomplete outcome data (attrition bias) 
 All outcomes High risk Missing data: Group 1 ‐ 27/72 (38%) (withdrew (1 because of adverse effects)). Group 2 ‐ 29/69 (42%) (withdrew (1 because of adverse effects)).
 i.e. similar rate missing in both groups; high rate – more than control event rate
Selective reporting (reporting bias) Low risk Adequate ‐ full results reported
Other bias 
 unit of analysis Low risk Unit of randomisation person and unit of analysis person (1 ulcer/person)
Other bias 
 additional Unclear risk Insufficient information to assess whether an important risk of bias exists
ALL‐DOMAIN RISK OF BIAS High risk Rating: very high
 Comments: unclear selection bias: baseline differences for proportion of Stage 4 ulcers (34% vs 41%); translated as 'not blinded'; attrition bias
ALL‐DOMAIN RISK OF BIAS 2 High risk